ABSTRACT The biochemical signaling pathways involved in nitric oxide (NO)-mediated cholinergic inhibition of L-type Ca 2+ current (Ic, tL1) were investigated in isolated primary pacemaker cells from the rabbit sinoatrial node (SAN) using the nystatin-perforated whole-cell voltage clamp technique. Carbamylcholine (CCh; 1 v.M), a stable analogue of acetylcholine, significantly inhibited/C~<L) after it had been augmented by isoproterenol (ISO; 1 ~M). CCh also activated an outward K + current, IKC^Ch)-Both of these effects of CCh were blocked completely by atropine. Preincubation of the SAN cells with L-nitro-arginine methyl ester (L-NAME; 0.2-1 mM), which inhibits NO synthase (NOS), abolished the CChinduced attenuation of/C~r but had no effect on IaC^Ch). Coincubation of ceils with both L-NAME and the endogenous substrate ofNOS, L-arginine (1 mM), restored the CCh-induced attenuation of/C,r indicating that L-NAME did not direcdy interfere with the muscarinic action of CCh on IC~CL). In the presence of ISO the CCh-induced inhibition of IC~r could be mimicked by the NO donor 3-morpholino-sydnonimine (SIN-l; 0.1 mM). SIN-1 had no effect on its own or after a maximal effect of CCh had developed, indicating that it does not inhibit Ice,L) directly. SIN-1 failed to activate Ig(^Ch), demonstrating that it did not activate muscarinic receptors. Both CCh and NO are known to activate guanylyl cyclase and elevate intracellular cGMP. External application of methylene blue (10 ItM), which interferes with the ability of NO to activate guanylyl cyclase, blocked the CCh-induced attenuation of/C~r However, it also blocked the activation of IKCACh), suggesting an additional effect on muscarinic receptors or G proteins. To address this, a separate series of experiments was performed using conventional wholecell recordings with methylene blue in the pipette. Under these conditions, the CCh-induced attenuation of IC~r was blocked, but the activation of IgCACh) was still observed. Methylene blue also blocked the SIN-l-induced decrease in IC~tL). 6-anilino-5,8-quinolinedione (LY83583; 30 tzM), an agent known to decrease both basal and CCh-stimulated cGMP levels, prevented the inhibitory effects of both CCh and SIN-1 on/C~r but had no effect on the activation of IK(ACh) by CCh. In combination, these results show that CCh-and NO-induced inhibition of IC~r is mediated by cGMP. CCh could not decrease/CaCL) after it had been increased maximally by a membrane-permeable cAMP analogue, 8-(4-chloropheAddress correspondence to Dr. W. R. Giles, Departments of Medical Physiology and Medicine, The University of Calgary, Calgary, Alberta, Canada T2N 4N1. nylthio)-adenosine-3',5'-cyclic monophosphate (8-CPT-cAMP; 0.2 mM), which is resistant to the cAMP-specific phosphodiesterase (PDE). This finding suggests that neither the cAMP-dependent protein kinase (PKA) nor the biochemical events occurring subsequent to PKA activation are involved in the CCh-or NO-induced inhibition of Ica(L). ICa(L) was not changed significantly by the membranepermeable cGMP analogues 8-bromognanosine-3',5'-cyclic monophosphate (8-Br-cGMP; 0.25-0.5 raM) and 8-(4-chlorophenylthio)-guanosine-3',5'-cyclic monophosphate (8-CPT-cGMP; 0.25 mM). These compounds selectively activate cGMPdependent protein kinase (PKG); their effects therefore rule out a role of PKG in this NO-mediated, CCh-induced inhibition of IcatL ). A potent but nonspecific PDE inhibitor 3-isobutyl-l-methyl-xanthine (IBMX; 20 o,M) completely prevented the CCh-induced attenuation of/Ca(L). Taken together, these findings suggest that in mammalian primary pacemaker SAN cells (in the presence of ISO), NO-mediated cholinergic inhibition of ICa(L) is due to a cGMP-stimulated cAMP-specific PDE, which hydrolyzes cAMP and thus inhibits cAMP-dependent phosphorylafion of ICa(L ) channels. Since /Ca(L) is essential for normal pacemaker activity, this biochemical pathway represents an important new mechanism for autonomic (cholinergic) control of mammalian heart rate.
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INTRODUCTION
Rhythmic beating of the mammalian heart originates within primary pacemaker tissue in the sinoatrial node (SAN). Generation of each spontaneous pacemaker depolarization and action potential depends upon an interaction of several different ionic currents, and autonomic regulation of heart rate results from modulation of a number of these conductances by neurotransmitters (see Irisawa, Brown, and Giles, 1993) . Activation of the sympathetic nervous system accelerates heart rate by releasing noradrenaline, which then binds to [3-adrenergic receptors and increases both the L-type Ca 2+ current, IC~(L), and the hyperpolarization-activated inward current,/t (see Giles and Shibata, 1981; Brown, 1982; Tsien et al., 1986; Hartzell, 1988; Irisawa et al., 1993; DiFrancesco, 1993) . Conversely, stimulation of the parasympathetic (vagus) nerve releases acetylcholine (ACh), which decreases heart rate by (a) directly activating a K + current, IK(ACh), and inhibiting/land by (b) antagonizing the effects of noradrenaline by reducing IcatL), the so-called indirect effect (Hartzell, 1988 : Irisawa et al., 1993 DiFrancesco, 1993) . This negative chronotropic effect of ACh in mammalian heart is mediated by the M2 subtype of muscarinic receptors (Hartzell, 1988) .
A number of different membrane-bound, heterotrimeric GTP-binding proteins (G proteins) participate in the signal transduction cascade initiated by sympathetic and parasympathetic stimulation (Gilman, 1987; Brown, 1990; Eschenhagen, 1993) . For example, the G protein C~ mediates ~adrenoceptor stimulation through two principal pathways. One of these is a membrane-delimited or direct pathway in which there are interactions between C~ and some of the ion-selective channels, e.g.,/land ICa<L) (Brown, 1990; but see Clapham, 1994) . This direct pathway does not involve biochemical second messengers. In contrast, the indirect pathway mediated by C~ requires activation of adenylyl cyclase, which results in increased cAMP levels, stimulation of cAMP-dependent protein kinase (PKA), and an increase in the phosphorylation of a number of target proteins, including ICa(L) channels (Hartzell, 1988; McDonald, Pelzer, Trautwein, and Pelzer, 1994) . Both the direct and the indirect stimulatory effects are decreased after activation of the inhibitory G protein (Gi), which couples M~ receptors to at least three different membrane currents: II~(ACh) and/f, which are inhibited directly, and ICa(L), which is inhibited indirectly (Gilman, 1987; Hartzell, 1988; Brown, 1991; DiFrancesco, 1993; Irisawa et al., 1993; Eschenhagen, 1993; Clapham, 1994) .
In the myocardium, the indirect action of ACh is thought to be mediated by a pertussis toxin-sensitive G protein, Gi, which is coupled to M~ receptors (Hescheler, Kameyama, and Trautwein, 1986; Fischmeister and Shrier, 1989; Nakajima, Wu, Irisawa, and Giles, 1990) . However, many details of the mechanism by which Gi inhibits Ica0. ) are still unresolved (Fleming, Wisler, and Watanabe, 1992; Eschenhagen, 1993) . Although high concentrations of the Or. i subunit of Gi directly inhibit adenylyl cyclase, this inhibitory effect is only partial and is dependent on the subtype of this enzyme (Taussig, Iniguez-Lluhi, and Gilman, 1993) . The [3~/subunits from Gi can directly inhibit the type-I brain adenylyl cyclase, but this isoform has not been identified in heart (Tang and Gilman, 1991) , suggesting that other mechanisms (in addition to adenylyl cyclase inhibition) must be involved in the AChinduced inhibition of Ica(L). A plausible alternative is that the ACh-induced attenuation of ICaIL ) is mediated by cGMP (Hartzell, 1988) . cGMP interacts with at least three intracellular sites: cGMP-regulated ion channels, cGMP-dependent protein kinase (PKG), and cGMP-regulated cyclic nucleotide phosphodiesterases (PDEs) (Lincoln and Cornwell, 1993) . A cGMP-stimulated PDE that hydrolyses both cAMP and cGMP is present in heart (Hartzell, 1988; Beavo and Reifsnyder, 1990) . In amphibian cells, cGMP activates a cGMP-stimulated cAMP-specific PDE that hydrolyses cAMP and thereby decreases /Ca(L) after it has been augmented by cAMPelevating agents, e.g., fl-adrenergic agonists (see Hartzell, 1988) . On the other hand, a cGMP-dependent protein kinase plays a major role in the cGMP-induced decrease in /Ca(L) in mammalian myocardium (Levi, Alloatti, and Fischmeister, 1989; Mery, Lohmann, Walter, and Fischmeister, 1991; Mery, Pavoine, Belhassen, Pecker, and Fischmeister, 1993) . /Ca(L) is essential for normal pacemaker activity (Irisawa et al., 1993) . Modulation of this current therefore represents an important mechanism for the autonomic control of heart rate. It is known that "physiological" vagal stimulation by a low dose of ACh significantly decreases the spontaneous firing rate without changing the maximum diastolic potential of the SAN, as expected for a selective inhibition of/Ca(L) (see Irisawa et al., 1993) . However, the signal transduction pathway that leads to this ACh-induced attenuation of/Ca(L) has not been investigated in detail in the SAN of the mammalian heart (Petit-Jacques, Lenfant, 1993, 1994) .
Muscarinic receptor activation by ACh is known to release nitric oxide (NO), and recent evidence has demonstrated that NO is an important second messenger involved in mediating the actions of neurotransmitters in the cardiovascular and central nervous systems (Bredt and Snyder, 1990; Bredt, Hwang, and Snyder, 1990; Moncada, Palmer, and Higgs, 1991; Flnkel, Oddis, Jacobs, Watkins, Hattler, and Simmons, 1992; Calver, Collier, and Vallance, 1993; Dinerman, Lowenstein, and Snyder, 1993 
METHODS

Cell Isolation
The technique used for isolation of single cells was the same as that described previously (Han, Habuchi, and Giles, 1994a; Han, Shimoni, and Giles, 1994b) .
Solutions
The bicarbonate-buffered Tyrode's solution used for Langendorff perfusion of the whole heart contained (in millimolar): 121 NaCI, 5.0 KC1, 2.8 sodium acetate, 1.0 MgCI~, 1.0 Na2HPO4, 24 NaI-ICOs, 5.5 glucose, and 1.0 CaCI~. This solution was equilibrated with 95% O~ and 5% CO~ (pH 7.4). The KB solution (Isenberg and Klockner, 1982) used for storing the cells contained (in millimolar): 90 potassium glutamate, 10 potassium oxalate, 25 KCI, 10 KH~PO4, 0.5 EGTA, 1.0 MgSO4, 20 taurine, 5 HEPES (~:2-hydroxyethylpiperazine-bg2-ethanesulfonic acid), and 10 glucose (pH adjusted to 7.2 with KOH). The HEPES-buffered Tyrode's solution in which all experiments were performed contained (in millimolar): 145 NaCI, 5.4 KCI, 1.0 MgCIg, 1.0 Na2HPO4, 5.0 HEPES, 1.8 CaCI~, and 10 glucose (pH adjusted to 7.4 with NaOH).
Recording Methods and Data Acquisition
In most experiments, the nystatin (0.4 mg/ml) perforated patch technique (Horn and Marty, 1988) in the whole-cell configuration (Hamill, Marty, Neher, Sakrnann, and Sigworth, 1981 ) was used to current and voltage clamp these cells. The pipette solution contained (in millimolar): 140 KC1, 6 NaCI, 1 MgCI~, and 5 HEPES (pH was adjusted to 7.2 with KOH). DC resistance was 1-3 MI~. Nystatin was first dissolved in dimethylsuffoxide and then added to the pipette solution. In a few experiments, the conventional suction microelectrode ruptured patch whole-cell method was used. In these experiments, the pipette solution included (in millimolar): 95 potassium aspartate, 30 KCI, 5 HEPES, 3 Na2phosphocreatine, 0.1 GTP (Na), 3 KeATP, 10 EGTA (ethyleneglycol-bis-(flaminoethylether)-N,N,N'N'-tetraacetic acid) , 1 CaCI~, and 1 MgCI~ (pH adjusted to 7.2 with KOH). The electrode resistance was between 2 and 4 M~. All recordings were made at 32-33~ Membrane currents were digitized at 2.5 kI-Iz. The volume of the recording chamber was 0.5 ml, and a constant flow rate of 1.5 ml/min was used to supeffuse the cells. 
Statistics
Statistical significance was evaluated using an unpaired t test, where appropriate. Means with values of P < 0.05 were considered to be significantly different.
RESULTS
NO Involvement in Muscarinic Cholinergic Inhibition of lc~L~
In a previous short communication (Hart et al., 1994) , we demonstrated that in rabbit SAN cells, inhibition of NOS by incubation in L-NMMA--containing Tyrode's solution for 10-20 rain resulted in complete loss of the ability of CCh to attenuate Ice,n). In the current study, we first confirmed this finding using a different NOS inhibitor, L-NAME (see Moncada, 1992) . Fig. 1 shows a typical set of results. To obtain a consistent inhibitory effect, the SAN cells had to be incubated with relatively high concentrations of L-NAME (0.2-1 raM) for a long period (at least 3 h). This may be because L-NAME is an esterified analogue of arginine and must be deesterifled before it is able to act on NOS (see Moncada, 1992) . The rate of action of the appropriate intracellular esterase(s) may account for the necessity of high concentrations of L-NAME and lengthy exposure times, which have both been described previously (Balligand et al., 1993) . Fig. 1 compares results obtained under control conditions. (Fig. 1 A) and after incubation in L-NAME (Fig. 1 B) . The three superimposed current traces in Fig. 1 A show that ISO (1 I~M) enhanced Ice,n) (a and b) and that CCh (1 I~M) markedly attenuated this effect, as well as producing an outward shift in the holding current (c) that is due to activation of IKCAeh). Fig. 1 B shows corresponding current traces from a different cell that had been incubated in 1 mM L-NAME for 4 h. Under these conditions, ISO enhanced Ic~r (a and b), but CCh no longer attenuated it. Note, however, that the outward current, IKCACh), still developed after CCh treatment (c). When the NOS inhibitor L-NMMA was used in this protocol, the pattern of results shown in Fig. 1 , A and B, could be obtained in the same cell (Han et al., 1994 ). This could not be done with L-NAME, because the inhibitory action of this compound required a very long preincubation (before recording), and its effects were very slow to wash off. cent reduction (mean -+ SEM) of ISO-stimulated ICaCL). CCh alone reduced peak amplitude to 57 +_ 4% of its magnitude in ISO (n = 24). After L-NAME incubation, peak amplitude of Ica was 113 + 7% (n = 11), owing to the inhibitory effect of L-NAME on NOS and the resulting decreased NO production. Finally, note that the coincubation of cells in L-NAME with 1 mM L-arginine (the endogenous substrate of NOS) restored the ability of CCh to attenuate Ica~L), i.e., /Ca(L) Was reduced to 57 ---6% (n = 4). The ability of CCh to attenuate/Ca(L) and of atropine to reverse this attenuation (data not shown), after up to 6 h of incubation in E-NAME, indicate that this NOS inhibitor does not directly interfere with other actions of the muscarinic agonist (e.g., its binding to receptors). Thus, although it has been suggested that I.-NAME may act as a muscarinic antagonist (Buxton, Cheek, Eckman, Westfall, Sanders, and Keef, 1993), we find no evidence for this in SAN cells. Our earlier work demonstrated that the NO donor SIN-1 had no effect in the absence of ISO, but that it attenuated ISO-stimulated/Ca(L) and did not further reduce IC~(L) after maximal inhibition by CCh (Han et al., 1994) . A prediction from these earlier results was that SIN-l, by directly supplying NO (bypassing NOS), should still attenuate /C~(L) in the presence of the NOS inhibitors. In the current experiments ( Fig. 2) , we found when CCh-induced attenuation of IC~(L) was inhibited by L-NMMA, addition of SIN-1 to the same cell indeed could still reduce/Ca(L).
Is cGMP Involved in These Actions of NO?
In many tissues, NO can activate guanylyl cyclase(s) (GC), which then generates cGMP. We therefore attempted to inhibit the action of NO on Ica(e) in myocytes from rabbit SAN by applying methylene blue, a compound that can block NO-induced activation of GC Harding, 1993; Mery et al., 1993) . In six cells, 5--10 vLM methylene blue completely blocked the action of CCh on IC~(L) in SAN cells. The peak amplitude of/Ca(L) was 97 --3% (n = fi) of the value in ISO plus methylene blue. However, in addition to blocking the inhibitory effect of CCh on ICatL), the activation of IK(ACh) was also inhibited completely. This pattern of results is illustrated in Fig. 3, A applied first, the subsequent addition of methylene blue reversed both CCh effects; i.e., it increased/Ca(L), and shifted the holding current inward, to its pre-CCh level. This result, seen in three cells, is shown in Fig. 3 C. A plausible explanation for these findings is that methylene blue can act as an antagonist at the muscarinic receptor. If this is the case, methylene blue-induced blockade of CCh effects cannot be taken as convincing evidence for an NO-induced activation of guanylyl cyclase in the muscarinic action of CCh. To address this question, two series of experiments were performed. In the first, the suction electrode whole-cell method of recording was used, to enable intracellular dialysis with methylene blue. Although the rundown of/Ca(L) tends to be faster when using this method, the pipette solution used (see Methods) allowed sufficiently stable recordings over the required time period (15--25 min). With this protocol, in eight cells, CCh activated IK(ACh) (because no methylene blue was present in the perfusate), yet it failed to attenuate ICatL) (Fig. 3 D) . The mean value of peak ICatL) after CCh addition was 95 _+ 3% of the value in ISO alone, which strongly supports NO involvement in CCh action. In the second series of experiments, SIN-l, an NO donor, was used in an independent test of this interpretation of the effects of methylene blue. SIN-1 directly releases NO, thus bypassing muscarinic receptor and G protein activation. In the presence of ISO, SIN-1 reduced peak Ic~(L> to 58 _ 4% of the amplitude in ISO alone (n = 19). This effect of SIN-1 was blocked by methylene blue (n = 5; Fig. 4, A and B) , as shown previously by Mery et al. (1993) . The peak IC~(L) in SIN-1 in the presence of ISO and methylene blue, was 98 ___ 4% of its magnitude in ISO and methylene blue. Fig. 4 Guanylyl cyclase activation will elevate intracellular cGMP, which is one of the mediators of the muscarinic cholinergic effects on IC~<L) in working myocardium (Watanabe and Besch, 1975; Hartzell, 1988; Levi et al., 1989) . To determine if this biochemical cascade is involved in the SAN, cells were exposed to ISO and CCh in the presence of LY83538, a compound that strongly inhibits both basal and CChstimulated cGMP production (Schmidt, Sawyer, Truex, Marshall, and Fleisch, 1984; Diamond and Chu, 1985; Mulsch, Luckhoff, Pohl, Busse, and Bassenge, 1989 ISO, but it blocked the inhibitory action of CCh on this current, without altering the activation in IKtACh). The mean value of ISO-stimulated IcatL ) after exposure to CCh, in the presence of LY83538, was 92 -5% of the value in ISO. An example of this pattern of results is shown in Fig. 5 . of SIN-1 on ISO-stimulated/Ca(L)* The mean magnitude of/Ca(L) in SINol alone was 58 -+ 4% of its magnitude in ISO; and after application of LY83538, itwas 103 _+ 4% (Fig. 6, A and B) . In two cells, LY83538 was washed off, and a second exposure to S1N-1 also produced the expected attenuation in ICa(L) (Fig. 6 C) . A summary of the effects of LY83538 on the attenuation of ICa(L) by both CCh and SIN-1 is shown in To obtain more information about the biochemical mechanisms responsible for the observed muscarinic attenuation of ICa{L), the biochemical events following elevation in cGMP were investigated. In frog myocardium, cGMP stimulates a PDE that augments cAMP breakdown (Hartzell, 1988; Simmons and Hartzell, 1988; Mery et al., 1993) , thereby attenuating the ISO-stimulated ICa{L). In mammalian ventricle, on the other hand, cGMP activates (a cGMP-dependent protein kinase) PKG, which leads to a reduction of/CalL ) (Levi et al., 1989; Mery et al., 1991) . We therefore studied whether either of these two mechanisms are operative in mammalian cardiac primary pacemaker cells.
FIGURE 6. Effects of LY83538 on SIN-1 attenuation of/Ca(L). (A) Time course of ICa(L) (O) and holding current (O) in control (a), ISO + LY83538 (b), and after exposure to 0.1 mM SIN-1 (c). (B) Superimposed current traces corresponding to points oo b, and c in
Effects of Cyclic Nucleotide Analogues
Cyclic nucleotide analogues that are not hydrolyzed by intracellular PDE provide a useful experimental approach for evaluating the possible involvement of cyclic nucleotide--dependent PDE in the observed effects of NO. We exposed SAN cells (n = 6) to a membrane-permeable analogue of cAMP, CPTw.AMP, which directly activates PKA and is not degraded by PDE, thus resulting in a marked increase in Ica{e). The effect of this compound on Ica{L} is similar to that of ~adrenergic agonists. However, it bypasses the receptor-dependent, G-mediated activation of adenylyl cyclase, and its effects are maintained, as opposed to transient. In six cells, the mean augmentation of Ica~L) Was 183.5 +--25.8% of the control magnitude. Moreover, after CPT-cAMP (0.2 raM), Ica{L) was no longer reduced by CCh. The mean current amplitude after CCh treatment was 96.1 _ 4.0% of the prior value (Fig. 7) . In two cells, CPTw.AMP was washed out and ISO was then introduced (point d in Fig. 7 , A and C). Under these conditions (in the presence of normal ~adrenergic activation), CCh markedly reduced ICa{L) (point e in Fig. 7, A and C) . Subsequently, after ISO was removed and CPTw.AMP was added, the inhibitory action of CCh on /Ca(L) was partially reversed (point fin Fig. 7, A and C) . This set of results implies that/CalL) can be attenuated by CCh only when cAMP can be degraded by a PDE. Note that the outward current, IK{ACh), activated by CCh is present under both conditions (CPT-cAMP and ISO), i.e., it is not dependent on these cyclic nucleotide levels. These results rule out any site of action that is at or subsequent to the activation of PKA in the CCh/NO-induced attenuation of ICa{L). For example, the enhancement of phosphatase activity and the resulting dephosphorylation of the IcatL) channel would still occur in the presence of CPTw.AMP.
CCh-induced inhibition of Ica{L) may result from an inhibition of adenylyl cyclase, as has been suggested previously in mammalian ventricle and atrium (Hescheler et al., 1986; Nakajima et al., 1990) . This is thought to occur through muscarinic activation of G i, which directly inhibits the G~ stimulation of adenylyl cyclase resulting from [$-adrenergic receptor occupation. This possibility was evaluated (n = 5) in rabbit SAN cells, to which ISO was added with (or after exposure to) 10-20 p,M IBMX, a nonselective inhibitor of a number of different PDEs. IBMX was applied with ISO to ensure that adenylyl cyclase was also activated. The combination re-A THE JOURNAL OF GENERAL PHYSIOLOGY 9 VOLUME 106 9 1995 suited in a mean increase in/Ca(L) to 162.5 -+ 8.5% of its control value. Subsequent addition of CCh produced no inhibitory effect on Ic~(g) (the mean value after CCh was 118.8 _+ 5.7% of the value before CCh); however, an outward shift in the holding current, signifying activation of IK<ACh), was present. IBMX was then washed out 8-Br-cGMP and 8-CPT-cGMP, were used. Both of these analogues strongly and selectively activate PKG and are insensitive to breakdown by PDE (Lincoln and Cornwell, 1993; Geiger, Nolte, Butt, Sage, and Walter, 1992) . Results from these experiments are shown in Fig. 9 . Neither 8-Br-cGMP nor CPT-cGMP, when added after ISO, had an inhibitory effect on ISO-stimulated Ira(L). The mean (n = 5) peak Ic~(L) amplitude in 8-Br-cGMP was 103.8 _+ 2.2% (relative to ISO alone), and that in 8-CPT-cGMP was 93.9 _ 3.0% of the amplitude in ISO alone (n = 4), suggesting that PKG activation cannot attenuate ICe,L). In the presence of 8-Br-cGMP to CCh reduced IC~tL) tO 56.2 --7.1% of the value in ISO; and in the presence of 8 CPT-cGMP IC~tL) was reduced to 61.4 _ 9.6%. These findings suggest that cGMP resulting from CCh actions can reduce ICe,L), presumably by activation of a PDE which enhances
lk( &c FIGURE 10. Diagram of our working hypothesis describing the cellular signaling pathways for NO-mediated cholinergic inhibition of/C~(L) in the presence of adrenergic tone in rabbit SAN. Activation of NOS after the binding of CCh to the M~ receptor results in NO production. This is blocked by L-NMMA or L-NAME, but this inhibition can be reversed by application of excess L-arginine. The NO donor SIN-1 directly provides NO, which stimulates guanylyl cyclase (GC) and elevates cGMP levels. Guanylyl cyclase activation is blocked by methylene blue (MB), and formation of cGMP is more selectively inhibited by LY83538. In this scheme, cGMP stimulates both the cGMP-dependent protein kinase (PKG) and the cGMP-stimulated cAMP-specific PDE. Blocking PDE by IBMX or the application of a nonhydrolyzable cAMP analogue, CPT-cAMP, prevents the CCh-or NO-induced reduction of Icale ). Two cGMP analogues that activate PKG without affecting PDE activity do not prevent the reduction of/Ca(L) by CCh. In this scheme, it is the cGMP-activated cAMP-specific PDE that hydolyzes ISO-elevated cAMP and decreases the/Ca(L). cAMP breakdown. In contrast, the nonhydrolyzable analogues of cGMP that do not stimulate this class of PDE are without effect on IC~(L).
DISCUSSION
Summary of Findings
Our results from primary pacemaker (SAN) cells of rabbit heart can be summarized using a pharmacological/biochemical working hypothesis that describes the cascade of events involved in cholinergic inhibition of L-type Ca 2+ current, IC~(L). This scheme and the interventions that we have used to test its validity are shown in Fig. 10 . Under physiological conditions, the attenuation of IC~<L), which is essential for the slowing of heart rate (Irisawa et al., 1994) , takes place in the presence of a steady or background adrenergic tone. Under these conditions, modulation of IC~(L) can occur at very low concentrations of ACh, which activate little if any outward K + current, IlqACh) (see Irisawa et al., 1994) . In all of our protocols, adrenergic tone was mimicked by application of ISO; and a relatively high concentration of the muscarinic agonist CCh (1 I~M ) was used to ensure that IKtAChl was also activated. IKthChl, which was measured as an outward shift in the holding current (at -40 mV), provided an internal control so that a functional muscarinic response could be verified in all recordings.
Three important issues concerning the physiological modulation of IcatL) have been clarified by our results. First, the involvement of NO as an obligatory mediator of muscarinic cholinergic responses in the SAN in the presence of ISO was confirmed (see Han et al., 1994) . This was done using two different inhibitors of NOS, either L-NAME or L-NMMA. Preincubation of cells with either compound consistendy prevented the inhibitory action of CCh on ICalL) and this effect could be overcome by coincubation with an excess of L-arginine, the endogenous substrate of NOS (Figs. 1 and 2 ). In addition, the NO donor SIN-l, which can mimic the inhibitory effect ofCCh (Han et al., 1994) , was shown to retain its effect in the presence of L-NAME or L-NMMA (Fig. 2) . Our results also demonstrate that the effects of CCh and of SIN-1 can be blocked by methylene blue, which is known to interfere with NO-induced activation of guanylyl cyclase and to decrease cGMP levels (Figs. 3 and 4). However, methylene blue blocked the effects of CCh on both /Ca(L) and /K(ACh), indicating that this compound has nonspecific effects (possibly muscarinic receptor blockade) in addition to inhibition of guanylyl cyclase.
The second important outcome from our work is the demonstration that in mammalian SAN cells the effects of CCh and of SIN-1 on/Ca(L) Can be inhibited by the compound LY83538. Because LY83538 significantly reduces intracellular cGMP levels, this result strongly suggests that the NO-mediated inhibition Of/Ca(L) involves the generation of cGMP in rabbit SAN. Furthermore, LY83583 had no effect on activation of IK~ACh), a muscarinic response that is not dependent on cGMP levels. Third, our findings also suggest that cGMP-dependent activation of a cAMP-specific PDE is an important step in the indirect muscarinic modulation of IcalL). Increased activity of this isoform of PDE would be expected to decrease cAMP levels and reduce the phosphorylation of the L-type Ca 2+ channels (Simmons and Hartzell, 1988) . Accordingly, in the presence of nonhydrolyzable analogues of cAMP or the nonselective PDE inhibitor IBMX, CCh was without effect (Figs. 6 and 7; see also Wang and Lipsius, 1994) . This finding rules out any direct inhibition of a cAMP-dependent protein kinase (PKA) by CCh, or a modulation of biochemical events subsequent to activation of PKA, e.g., enhanced dephosphorylation of the L-type Ca ~+ channel by phosphatases. The lack of an inhibitory effect of CCh on /Ca(L) in the presence of ISO and IBMX or the nonhydrolyzable analogue of cAMP or CPT-cAMP strongly suggests that the inhibition of adenylyl cyclase by CCh (or elevated cGMP) does not play a significant role in the attenuation of Ic~tL) in rabbit pacemaker cells. However, it is conceivable that intracellular cAMP reaches saturating levels after exposure to IBMX and ISO, leading to maximal augmentation of Ica~L)-Under these conditions, CCh-induced decreases in the rate of cAMP formation might go undetected, because a sufficiently high concentration of cAMP may still be present to give maximal IC~IL). To test this possibility, we applied IBMX after CCh (Fig. 8, e and f) . Under these conditions, if the major effect of CCh was to inhibit ISO-stimulated adenylyl cyclase, cAMP levels would be very low, IBMXinduced inhibition of PDE would have very small effects, and the resulting increase in cAMP and ICa(L)would be expected to be small. In fact, the effects of IBMX on /ca(L) were very similar whether it was applied before or after CCh (see Fig. 8 ), implying that CCh does not act mainly on the adenylyl cyclase in rabbit SAN. Although elevated cGMP levels in response to CCh application and/or NO production can stimulate PKG, this enzyme does not appear to play a significant role in the cholinergic attenuation of IcaiL ) in rabbit SAN (Fig. 9) , because membrane-permeable analogues of cGMP failed to change ICa(L) significantly. This is in contrast to the effects of CCb, which markedly reduced ICaIL ).
Relation to Previous Work
The muscarinic modulation of 1Ca(L) is known to involve two different biochemical pathways depending upon the species or cardiac tissue being studied. In mammalian ventricular cells (Levi et al., 1989; Mery et al., 1991) cGMP-dependent activation of a protein kinase (PKG) is necessary for the reduction in IC~(L). On the other hand, in frog myocardium (Hartzell, 1988; Mery et al., 1993) , the most important biochemical reaction appears to be cGMP-induced stimulation of a PDE, which then selectively breaks down cAMP. The resulting reduction in cAMP levels attenuates 1CalL ). Our data show that in mammalian pacemaker cells the biochemical scheme that has been identified in frog ventricle is operative.
Limitations of Our Approach
Our data are consistent with, but do not unequivocally prove, the working hypothesis outlined in Fig. 10 . For example, if IBMX or 8-CPT~AMP can inhibit adenylyl cyclase indirectly, perhaps through a negative feedback control mechanism activated by very high levels of cAMP (see Iyengar, 1993) , no further inhibition of adenylyl cyclase by CCh would be observed. In addition, a cGMP-induced inhibition of PKA or a cGMP-dependent activation of a phosphatase that acts directly on /Ca(L) channels might be effective in the presence of cAMP, but conceivably may not occur in the presence of the cAMP analogue CPT<AMP. The isoform of the PDE activated by cGMP needs to be identified in SAN cells. Further work is also required to elucidate how NOS is activated after application of muscarinic agonists.
